Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Other Working Capital Changes (2017 - 2025)

Catheter Precision (VTAK) has disclosed Other Working Capital Changes for 9 consecutive years, with -$1000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes fell 100.97% to -$1000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $100000.0, a 110.11% increase, with the full-year FY2024 number at -$3000.0, up 99.66% from a year prior.
  • Other Working Capital Changes was -$1000.0 for Q3 2025 at Catheter Precision, down from $64000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $616000.0 in Q2 2023 to a low of -$881000.0 in Q4 2023.
  • A 5-year average of -$80722.2 and a median of -$78000.0 in 2024 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: plummeted 288.49% in 2022, then surged 10200.0% in 2024.
  • Catheter Precision's Other Working Capital Changes stood at -$280000.0 in 2021, then decreased by 19.64% to -$335000.0 in 2022, then crashed by 162.99% to -$881000.0 in 2023, then soared by 111.92% to $105000.0 in 2024, then plummeted by 100.95% to -$1000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Other Working Capital Changes are -$1000.0 (Q3 2025), $64000.0 (Q2 2025), and -$68000.0 (Q1 2025).